Physicians, lawmakers wary of pharma data mining
Patient Safety Monitor Alert, May 23, 2007
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
Physicians and lawmakers in several states are trying to block a pharmaceutical practice of mining data to learn about physician prescribing practices. Opponents of the tactic fear it gives private companies inappropriate access to sensitive medical data and could improperly influence a patient's prescription, according to a Washington Post article.
The companies maintain that the data mining helps to target marketing, which reduces drug costs, and also gives them an opportunity to educate physicians about alternative treatments.
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q&A: Coding for dry skin due to cold weather
- Q/A: Volume requirement for reporting hydration services
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Privacy, security concerns high in HIEs
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- HIPAA Q&A: TPO disclosures to a business associate
- Are your workforce members texting PHI?
- Q&A: Coding for dry skin due to cold weather
- What does case-mix index mean to you?
- Hospitalist-surgeon comanagement has no effect on outcomes
- Don't let these sentinel events trigger falsely
- Searched
